重组副肌球蛋白联合Montanide ISA206佐剂免疫水牛对日本血吸虫感染的保护作用
该研究开展三项疫苗试验,评估重组全长副肌球蛋白(rSj97)以ISA206为佐剂、按250μg/剂或500μg/剂、间隔4周共3剂免疫水牛后,攻击感染1000条日本血吸虫尾蚴的保护效果;主要结局为攻击后8-10周经门静脉灌注评估的虫负荷。三剂方案耐受良好,500μg/剂组虫负荷较对照降低57.8%(p=0.026;p=0.014),250μg/剂组降低60.9%但未达统计学显著。
要点
- rSj97三剂方案在水牛中耐受良好,安全指标包括体重、体温、体况评分、血常规及肝肾功能常规检测。
- 500μg/剂组攻击后虫负荷较对照降低57.8%(p=0.026;p=0.014)。
- 250μg/剂组虫负荷降低60.9%,但未达统计学显著。
核心结论
- rSj97是水牛日本血吸虫病安全且有前景的疫苗候选。
研究设计与样本
- 开展三项疫苗试验,水牛经3剂rSj97联合ISA206佐剂免疫,剂量为250μg/剂或500μg/剂、间隔4周,随后攻击感染1000条日本血吸虫尾蚴。
- 主要结局为攻击后8-10周经门静脉灌注评估的虫负荷;安全性指标包括体重、体温、体况评分、血常规及肝肾功能常规检测。
主要发现
- 三剂方案在全部三项试验中耐受良好。
- 第一项试验中,免疫水牛攻击后虫负荷较对照降低51.5%。
- 第二项试验中,500μg/剂rSj97免疫水牛虫负荷较对照降低57.8%(p=0.026);250μg/剂组观察到60.9%的降低但未达统计学显著。
- 第三项试验中,500μg/剂rSj97免疫水牛虫负荷较对照降低57.8%(p=0.014)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Schistosomiasis japonica is a zoonosis and presents significant public health problems in China and the Philippines. Vaccines targeting domestic animals constitute attractive control measures. METHODS: We conducted three vaccine trials to evaluate the protective efficacy of recombinant full-length paramyosin (rSj97) in water buffalo. Animals were immunized with 3 doses of rSj97 adjuvanted with ISA206 at 250μg/dose or 500μg/dose at 4wk intervals before challenge with 1000 Schistosoma japonicum cercariae. The primary outcome was worm burden assessed by portal perfusion 8-10weeks post challenge. Safety measures included weight, temperature, body condition score, hemogram and routine assays for hepatic and renal function. RESULTS: The three-dose regimen was well tolerated in all three trials. In the first trial, vaccinated buffalo had 51.5% lower worm burden post challenge compared to controls. In the second trial, buffalo immunized with 500μg/dose of rSj97 had 57.8% lower worm burden compared to controls (p=0.026). A similar but not significant reduction (60.9%) was observed with animals administered with 250ug rSj97/dose. In the third trial, buffalo immunized with a 500μg/dose of rSj97 had 57.8% lower worm burden compared to controls (p=0.014). CONCLUSIONS: These findings indicated that rSj97 is a safe and promising vaccine candidate for schistosomiasis japonica in water buffalo.
引用
- Wu HW, Fu ZQ, Lu K, et al. Vaccination with recombinant paramyosin in Montanide ISA206 protects against Schistosoma japonicum infection in water buffalo. Vaccine. 2017. PMID: 28504194. doi:10.1016/j.vaccine.2017.05.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。